Noul showcases ai-powered cervical cancer cell screening technology at nvidia gtc 2025

Company joins nvidia healthcare & life sciences (hcls) ecosystem to advance global diagnostic accessibility and seeks partnerships with global healthcare opportunities yongin, south korea , march 20, 2025 /prnewswire/ -- noul co., ltd. a korea-based medical ai company, announced that it presented a poster titled "bridging medical gaps from malaria to cancer: on-device ai diagnostic solutions powered by nvidia jetson" at nvidia gtc 2025, the world's leading ai developer conference.
NVDA Ratings Summary
NVDA Quant Ranking